Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature|
|Citation:||Annals of Oncology, 2007; 18(1):197-198|
|Publisher:||Oxford Univ Press|
|TE Delea, J Karnon and PE Goss|
|Keywords:||Humans; Breast Neoplasms; Aromatase Inhibitors; Postmenopause; Cost-Benefit Analysis; Drug Costs; Female|
|Rights:||Copyright © 2006 European Society for Medical Oncology|
|Appears in Collections:||Public Health publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.